Oncotelic Therapeutics, Inc. (OTLC)
OTCMKTS · Delayed Price · Currency is USD
0.0500
+0.0100 (25.00%)
May 14, 2026, 12:36 PM EST
Oncotelic Therapeutics Market Cap
Oncotelic Therapeutics has a market cap or net worth of $19.22 million as of May 14, 2026. Its market cap has decreased by -15.92% in one year.
Market Cap
19.22M
Enterprise Value
32.02M
Revenue
n/a
Ranking
n/a
PE Ratio
0.07
Stock Price
$0.05
Market Cap Chart
Since April 23, 2019, Oncotelic Therapeutics's market cap has increased from 9.14M to 19.22M, an increase of 110.26%. That is a compound annual growth rate of 11.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 19.22M | -48.22% |
| Dec 31, 2025 | 37.13M | 160.46% |
| Dec 31, 2024 | 14.26M | -6.64% |
| Dec 29, 2023 | 15.27M | -13.24% |
| Dec 30, 2022 | 17.60M | -71.94% |
| Dec 31, 2021 | 62.72M | 225.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anebulo Pharmaceuticals | 21.21M |
| Arch Biopartners | 20.73M |
| Zeo ScientifiX | 16.72M |
| Galera Therapeutics | 16.18M |
| HOOKIPA Pharma | 15.18M |
| LianBio | 15.14M |
| Inhibitor Therapeutics | 14.33M |
| ZIVO Bioscience | 13.01M |